203 related articles for article (PubMed ID: 28580798)
1. Delaying of cataract through intervention of Hemidesmus indicus in STZ induced diabetic rats.
Tirumani P; Venu S; Sridhar G; Praveen Kumar M; Rajashekhar AV; Naga Raju T
Nat Prod Res; 2018 Jun; 32(11):1295-1298. PubMed ID: 28580798
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
[TBL] [Abstract][Full Text] [Related]
3. Promising anti-diabetes mellitus activity in rats of β-amyrin palmitate isolated from Hemidesmus indicus roots.
Nair SA; Sabulal B; Radhika J; Arunkumar R; Subramoniam A
Eur J Pharmacol; 2014 Jul; 734():77-82. PubMed ID: 24726843
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X
Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572
[TBL] [Abstract][Full Text] [Related]
6. Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo.
Chung YS; Choi YH; Lee SJ; Choi SA; Lee JH; Kim H; Hong EK
J Ethnopharmacol; 2005 Oct; 101(1-3):49-54. PubMed ID: 15905053
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
8. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
9. Anticataractogenesis and Antiretinopathy Effects of the Novel Protective Agent Containing the Combined Extract of Mango and Vietnamese Coriander in STZ-Diabetic Rats.
Wattanathorn J; Thiraphatthanavong P; Thukham-Mee W; Muchimapura S; Wannanond P; Tong-Un T
Oxid Med Cell Longev; 2017; 2017():5290161. PubMed ID: 28904737
[TBL] [Abstract][Full Text] [Related]
10. Anti-cataract effects of coconut water in vivo and in vitro.
Zhang X; Peng L; Dai Y; Xie Q; Wu P; Chen M; Liu C
Biomed Pharmacother; 2021 Nov; 143():112032. PubMed ID: 34488080
[TBL] [Abstract][Full Text] [Related]
11. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
Ciddi V; Dodda D
Pharmacol Rep; 2014 Oct; 66(5):799-803. PubMed ID: 25149983
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
[TBL] [Abstract][Full Text] [Related]
14. Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
Higashi Y; Higashi K; Mori A; Sakamoto K; Ishii K; Nakahara T
Biol Pharm Bull; 2018; 41(10):1586-1592. PubMed ID: 30270328
[TBL] [Abstract][Full Text] [Related]
15. The bioactive and therapeutic potential of Hemidesmus indicus R. Br. (Indian Sarsaparilla) root.
Das S; Bisht SS
Phytother Res; 2013 Jun; 27(6):791-801. PubMed ID: 22887725
[TBL] [Abstract][Full Text] [Related]
16. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
17. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
Suresha BS; Sattur AP; Srinivasan K
Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
[TBL] [Abstract][Full Text] [Related]
18. Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats.
Bahmani F; Bathaie SZ; Aldavood SJ; Ghahghaei A
Mol Vis; 2012; 18():439-48. PubMed ID: 22355255
[TBL] [Abstract][Full Text] [Related]
19. 2-hydroxy 4-methoxy benzoic acid isolated from roots of Hemidesmus indicus ameliorates liver, kidney and pancreas injury due to streptozotocin-induced diabetes in rats.
Gayathri M; Kannabiran K
Indian J Exp Biol; 2010 Feb; 48(2):159-64. PubMed ID: 20455325
[TBL] [Abstract][Full Text] [Related]
20. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
